Ontology highlight
ABSTRACT:
SUBMITTER: Fang Z
PROVIDER: S-EPMC10187239 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
bioRxiv : the preprint server for biology 20230503
Chemically modified antisense oligonucleotides (ASO) currently in pre-clinical and clinical experiments mainly focus on the 2'-position derivatizations to enhance stability and targeting affinity. Considering the possible incompatibility of 2'-modifications with RNase H stimulation and activity, we have hypothesized that the atom specific modifications on nucleobases can retain the complex structure and RNase H activity, while enhancing ASO's binding affinity, specificity, and stability against ...[more]